GlassScriptPhysician profile
Nathan Steinhafel
NPI 1437386927
$3,970.96
in general payments reported to CMS, 2019-2025
17 companies · $941 in 2025
The $941 reported for 2025 was more than what 93% of Pediatrics (Optometrist) providers received nationally (typical 2025 total: $152).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.03 · 2020: $107 · 2021: $498 · 2022: $830 · 2023: $757 · 2024: $794 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,492.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,091.40 | 2022-2025 | Miebo, Xiidra, Infuse |
| Alcon Vision LLC | $720.39 | 2020-2025 | Total30, Precision 1, Precision7 |
| Oyster Point Pharma, INC. | $447.13 | 2022-2025 | Tyrvaya, Ryzumvi |
| Johnson & Johnson Vision Care, INC. | $342.93 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $273.99 | 2021-2025 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $253.37 | 2019-2021 | |
| Coopervision INC. | $191.54 | 2021-2025 | Clariti Contact Lens, Biofinity Contact Lens, Myday Contact Lens |
| Tarsus Pharmaceuticals, INC. | $171.30 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $126.45 | 2021-2022 | |
| Abbvie INC. | $101.83 | 2022-2024 | Alphagan P, Lumigan, Vuity |
| Dompe US, INC. | $78.87 | 2024-2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $52.83 | 2021 | |
| Thea Pharma INC. | $42.28 | 2024-2025 | Iyuzeh |
| Allergan, INC. | $30.86 | 2021-2022 | |
| Harrow Eye, LLC | $20.01 | 2024 | Vevye |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $13.19 | 2022 | |
| Abb Con-Cise Optical Group LLC | $12.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Steinhafel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.